Research at Barts Health News

A Barts Health doctor whose research has helped to double the life expectancy of people with severe bladder cancer has been included in a list of the most influential scientists of 2023.

Barts Health is to become the centre of a new regional network for the whole of north London.

A participant in the Genes & Health study, run by Barts Health NHS Trust is among the first  people in the world to test a new treatment for managing high-cholesterol.

Newham Hospital’s maternity unit is taking part in a trial that aims to improve routine testing for group B Strep (GBS) during pregnancy. 

Clinical trial results show that a new combination of drugs doubles overall survival for patients with bladder cancer that has spread.